biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by fatboy92on Feb 13, 2019 2:36pm

160 Views

Post# 29359756

RE:What’s up?

BTI needs more deals, more news, more investors. Many shareholders have been here for 4 to 6 years or more and are fully invested. Buying more shares as the share price kept dropping. Tired of getting beat up by anonymous, Jock or whoever. Even the bashers have either converted, bought more or moved on. Except the hardest working Digital (aka. Sir holler) It's looking more and more the new management and BTI will succeed, however a trigger point and a influx of new buyers is desperately needed to kick some new life into this share price. JMHO

Bullboard Posts

Unique Battery Metals opportunity in Quebec